Bolden Therapeutics
Providence · Founded 2019
About Bolden Therapeutics
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Last round: Series Unknown (Jan 2024)
- Website: https://www.boldentherapeutics.com/
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bolden-therapeutics-20275 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.